Search
for
Sort by
Research 781–810 of 1000+
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Unraveling the secret life of the hair follicle: from fungi to innovative hair loss therapies
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Alopecia areata following COVID-19 vaccine: a systematic review
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Folliculitis decalvans responsive to tofacitinib: A case series
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- What is behind the ‘swarm of bees’ in alopecia areata
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- What’s New in Hair Loss
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- SDRIFE Induced by Tofacitinib
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Alopecias in humans: biology, pathomechanisms and emerging therapies